Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02658448 · ClinicalTrials.gov registry record · Phase 2
GTx-024 as a Treatment for Stress Urinary Incontinence in Women
A Phase 2 study, sponsored by GTx.
- Completed
- Registry status
- Phase 2
- Development phase
- 19
- Enrollment target
NCT02658448 is a Phase 2 study that has completed, run by GTx. The registered enrollment target is 19 participants.
The verdict
NCT02658448, a Phase 2 study, has completed, sponsored by GTx.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether GTx-024 is safe and effective in the treatment of stress urinary incontinence in postmenopausal women.
Interventions
- DRUG GTx-024
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2016-01 |
| Est. Completion | 2018-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02658448
The ClinicalTrials.gov registry entry for NCT02658448 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GTx, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GTx-024 is the first listed.
NCT02658448 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02658448 about?
NCT02658448 is a clinical study titled "GTx-024 as a Treatment for Stress Urinary Incontinence in Women". The purpose of this study is to determine whether GTx-024 is safe and effective in the treatment of stress urinary incontinence in postmenopausal women.
What is the current status of trial NCT02658448?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 19 participants. The study started on 2016-01. Estimated completion is 2018-06.
What interventions are being tested in trial NCT02658448?
The interventions under investigation include: GTx-024 (DRUG).
Who is sponsoring clinical trial NCT02658448?
This trial is sponsored by GTx, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.